Name: 글로벌 혈관조영기기 시장 - 2023-2030 - Prime research
SKU: DMMD1651
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 혈관조영기기 시장 규모는 2022년 YY백만 달러였으며, 2030년까지 YY백만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 6.2%입니다.
혈관조영기기는 신체의 혈관 및 장기 내부, 특히 동맥, 정맥, 심장 내강을 시각화하는 데 사용되는 의료 영상 장비입니다. 여기에는 혈관조영 시스템, 카테터, 가이드와이어, 풍선, 조영제, 혈관 폐쇄 장치 및 혈관조영 액세서리가 포함됩니다.
시장 동향
심혈관 질환 발병률 증가, 고령 인구 증가, 생활 방식 변화, 심혈관 질환에 대한 인식 제고 및 시장 개발은 전 세계 혈관조영기기 시장 성장을 촉진할 것으로 예상됩니다.
신제품 출시는 예측 기간 동안 전 세계 혈관조영기기 시장 성장을 견인할 것입니다.
혈관조영 분야의 신제품 출시는 예측 기간 동안 전 세계 혈관조영기기 시장 성장을 촉진할 것입니다. 예를 들어, 2020년 북미방사선학회(RSNA) 가상 회의에서 GE Healthcare는 Allia IGS 7 혈관조영 시스템을 공개했습니다. 이 시스템은 인공지능을 활용하여 회전식 혈관조영술의 활용도를 높입니다. 또한, 2021년 11월 Royal Philips는 획기적인 스펙트럼 CT 영상 기술을 하이브리드 혈관조영 CT 시스템에 통합하여 중재 시술 분야에 대한 비전을 제시했습니다. Philips는 자사의 고유한 Spectral CT 7500 시스템과 영상 유도 치료 시스템인 Azurion, 그리고 FlexArm을 단일 중재 시술 시스템 솔루션에 통합함으로써 시술자가 이 두 가지 핵심 영상 기법을 테이블 옆에서 즉시 이용할 수 있도록 지원할 계획입니다.
더불어, 2022년 4월 GE Healthcare는 Discovery IGS 740 모바일 혈관조영 시스템을 출시했습니다. 무선 방식의 Discovery IGS 740은 뛰어난 시술 공간 설계와 유연한 좌석 배치를 제공합니다. 레일이 없는 디자인과 조절 가능한 넓은 구경의 C-arm 위치 조정 기능은 시술자에게 탁월한 편안함과 제어력을 제공합니다. 또한, 이 제품의 대형 검출기는 2D와 3D 모두에서 광범위한 해부학적 구조를 커버합니다. 마찬가지로, 2022년 11월 Genesis MedTech Group은 TriReme Medical LLC가 설계한 Chocolate Touch 약물 코팅 풍선 PTA 카테터에 대해 미국 식품의약국(FDA)의 승인을 받았습니다. 이 카테터는 표재성 대퇴동맥과 슬와동맥의 말초동맥질환 환자 치료에 사용됩니다. 따라서 앞서 언급한 데이터는 제품 출시 증가가 예측 기간 동안 전 세계 혈관조영기기 시장 성장을 견인할 것임을 보여줍니다.
엄격한 규제와 높은 비용은 전 세계 혈관조영기기 시장 성장을 저해하는 요인입니다.
또한, 주요 시장 참여업체들의 반복적인 제품 리콜은 예측 기간 동안 전 세계 혈관조영기기 시장 성장을 억제하는 요인으로 작용하고 있습니다. 예를 들어, 2021년 7월 Medtronic은 병원으로 배송되기 전 멸균 처리가 되지 않았다는 이유로 혈관조영술 시 카테터를 삽입하는 데 사용되는 가이드와이어 부품 54,997개를 리콜했습니다. 또한, 2021년 9월, 코디스(Cordis)는 방사선 불투과성 마커 밴드가 움직이거나 잘못 위치할 가능성 때문에 방사선 불투과성 마커 밴드가 있는 SUPER TORQUE MB 혈관조영 카테터를 리콜했습니다. FDA는 이를 가장 심각한 리콜인 Class I 리콜로 분류했습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 혈관조영 기기 시장에 부정적인 영향을 미쳤습니다. 팬데믹 기간 동안 혈관조영 시술이 크게 감소했기 때문입니다. 예를 들어, 영국 심혈관 중재학회(British Cardiovascular Interventional Society)는 팬데믹으로 인한 봉쇄 기간 동안 영국에서 시행된 모든 경피적 관상동맥 중재술(PCI) 건수를 팬데믹 이전 기간의 PCI 건수와 비교하여 후향적 분석을 수행했습니다. 이 후향적 분석 결과 PCI 건수가 49% 감소했으며, 안정형 협심증 환자의 경우 66%, ST분절 상승 심근경색(STEMI) 환자의 경우 33% 감소하여 가장 큰 타격을 입었습니다. 또한, 팬데믹으로 인해 건강한 생활 습관에 대한 사람들의 인식이 바뀌었고, 이로 인해 심혈관 질환 발병 사례가 감소하여 전 세계 혈관조영 장비 시장에 부정적인 영향을 미쳤습니다.
세그먼트 분석
관상동맥 질환 관련 수요는 예측 기간(2022-2029년) 동안 높게 유지될 것으로 예상됩니다.
관상동맥 질환은 심장 동맥이 심장 근육에 충분한 산소가 풍부한 혈액을 공급하지 못하는 심장 질환입니다. 이는 사망 원인 1위입니다. 관상동맥 질환의 원인은 질환 유형에 따라 다릅니다. 관상동맥 질환은 일반적으로 콜레스테롤이라는 왁스 같은 물질이 관상동맥 내벽에 축적되어 플라크를 형성함으로써 발생합니다. 이러한 축적물은 심장의 큰 동맥에서 혈류를 부분적으로 또는 완전히 차단할 수 있습니다. 관상동맥 미세혈관 질환은 심장의 작은 혈관들이 정상적으로 기능하지 못할 때 발생합니다. 대부분의 경우, 관상동맥 질환은 건강한 생활 습관을 통해 예방할 수 있습니다.

관상동맥 질환 발병 사례가 증가함에 따라 관상동맥 조영술은 예측 기간 동안 전 세계 조영 장비 시장을 주도할 것으로 예상됩니다. 예를 들어, 미국 심장 협회(American Heart Association)는 2020년 전 세계적으로 2억 4,410만 명이 허혈성 심장 질환(IHD)을 앓고 있으며, 남성이 여성보다 더 많이 발병했다고 추산했습니다(남성 1억 4,100만 명, 여성 1억 310만 명). IHD 유병률이 가장 높은 지역은 북아프리카 및 중동, 중앙 및 남아시아, 동유럽이었으며, 사망률 또한 북아프리카, 중동, 동유럽, 중앙아시아에서 가장 높았습니다. 따라서 이러한 데이터는 관상동맥 조영술이 예측 기간 동안 전 세계 조영 장비 시장을 주도할 것임을 시사합니다.

지역 분석
북미 지역이 전 세계 조영 장비 시장을 주도할 것으로 예측됩니다.

북미 지역은 심혈관 질환 발병률 증가와 주요 시장 참여 기업들의 존재로 인해 예측 기간(2022-2029년) 동안 큰 시장 점유율을 차지할 것으로 예상됩니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 미국에서는 34초마다 한 명씩 심혈관 질환으로 사망합니다. 2020년에는 심혈관 질환으로 69만 7천 명 이상이 사망했습니다. 또한, Abbott, Haemonetics Corporation, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, Cook Medical Inc.와 같은 주요 시장 참여 기업들이 다양한 마케팅 전략을 통해 전 세계 혈관조영기기 시장에서 상당한 점유율을 확보하고 있으며, 이들 기업들이 미국에 기반을 두고 있어 북미 지역이 전 세계 혈관조영기기 시장을 주도할 것으로 전망됩니다. 예를 들어, 세계적인 의료 기술 기업인 텔레플렉스(Teleflex Incorporated)는 2022년 5월, 대구경 대퇴동맥 접근 부위 폐쇄를 위해 특별히 개발된 최초의 상용 생체역학적 혈관 폐쇄 장치인 MANTA 혈관 폐쇄 장치에 대해 캐나다 보건부(Health Canada)의 승인을 받았습니다. 이 승인은 MANTA 장치의 전 세계적인 보급 확대를 위한 규제 전략에 있어 중요한 이정표이며, 텔레플렉스가 독자적으로 개발한 또 다른 장치를 캐나다 의료진에게 제공할 수 있게 되었습니다.
또한, 환자 치료 결과 개선을 위한 혁신적인 의료 솔루션 제공에 주력하는 글로벌 의료 기술 기업인 헤모네틱스(Haemonetics Corporation)는 2021년 1월, 캘리포니아주 산타클라라에 본사를 둔 혈관 폐쇄 시스템 업계 선도 제조업체인 비상장 기업 카디바 메디컬(Cardiva Medical, Inc.)을 인수했습니다. 헤모네틱스는 이번 인수를 통해 규모가 크고 성장하는 중재 심장학 및 전기생리학 시장에 대한 시장 점유율을 강화했습니다. 따라서 이러한 데이터는 북미 지역이 전 세계 시장의 대부분을 차지하고 있음을 보여줍니다.

경쟁 환경
주요 글로벌 혈관조영기기 시장 참여 기업으로는 Abbott, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, B.Barun Melsungen, Siemens Healthineers, Lepu Medical, GE Healthcare, Haemonetics Corporation, 그리고 Cook Medical Inc. 등이 있습니다. 주요 기업들은 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 전략을 통해 글로벌 혈관조영기기 시장 성장에 기여하고 있습니다. 예를 들어, Lepu Medical은 2022년 10월 네덜란드 인증기관인 BSI Netherlands Notified Body(2797)로부터 Ultraskin Hydrophilic Guide Wire에 대한 MDR 인증을 획득하고 EU 시장 판매 승인을 받았습니다. 이 인증은 5년간 유효합니다. Ultraskin Hydrophilic Guide Wire는 Lepu Medical의 고위험군 III 제품 중 MDR 인증을 받은 두 번째 제품입니다.
Medtronic, Plc.

개요:
Medtronic plc는 아일랜드에 본사를 둔 미국 의료기기 회사입니다. 메드트로닉은 1949년에 설립되었으며 미국 미네소타주 미니애폴리스에 본사를 두고 있습니다. 메드트로닉은 최소 침습 치료 그룹, 당뇨병 그룹, 재건 치료 그룹, 심장 및 혈관 그룹의 네 가지 사업 부문을 운영하고 있습니다.
제품 포트폴리오:
메드트로닉의 혈관 조영 장치 제품 포트폴리오에는 Launcher가 포함되어 있습니다. Launcher는 시장 선도 기업으로서 기대되는 성능상의 이점을 제공하는 관상동맥 유도 카테터로, 경요골 및 대퇴 경피 관상동맥 중재술(PCI)을 위한 다양한 곡선 형태를 제공합니다.
글로벌 혈관 조영 장치 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량으로 구성되어 있습니다.

보고서 요약(영어 원문)

Market Overview
The global angiography devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 6.2% during the forecast period (2023-2030).
Angiography devices are medical imaging devices used to visualize the inside, or lumen, of blood vessels and organs of the body, with a particular interest in the arteries, veins, and heart chambers. These include Angiography Systems, Catheters, Guidewires, Balloons, Contrast Media, Vascular Closure Devices, and Angiography Accessories.
Market Dynamics
The rising cases of cardiovascular diseases, growing geriatric populations, lifestyle changes, increasing awareness about cardiovascular diseases, and market developments are expected to fuel the global angiography devices market growth.
The new product launches boost the global angiography devices market during the forecast period.
The new product introduction for angiography boosts the global angiography devices market during the forecast period. For instance, in the Radiological Society of North America (RSNA) virtual meeting in 2020, GE Healthcare revealed its Allia IGS 7 angiography system. The system utilizes artificial intelligence to amplify the use of rotational angiography. Also, in November 2021, Royal Philips disclosed its perception of interventional medicine by including its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. Philips expects to deliver interventionalists instantaneous table-side access to these two key imaging modalities by integrating the company's unique Spectral CT 7500 system and its Image-Guided Therapy System, Azurion, with FlexArm in a single interventional suite solution.
Additionally, in April 2022, GE Healthcare launched its Discovery IGS 740 mobile angiography system. The untethered Discovery IGS 740 delivers excellent room design and sitting flexibility. The Discovery's rail-free design and adjustable wide-bore C-arm positioning deliver exceptional comfort and control to the practitioners. Moreover, its large detector covers extensive anatomies in both 2D and 3D. Likewise, in November 2022, Genesis MedTech Group received the Food and Drug Administration (FDA) approval for its Chocolate Touch Drug-coated Balloon PTA Catheter, designed by TriReme Medical LLC, indicated for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery. Thus, the mentioned data indicates that the increasing product introductions drive the growth of global angiography devices in the forecasted period.
The stringent regulations and high costs hinder the global angiography devices market growth.
However, the reoccurring product recalls from the market by key market players are restraining the growth of global angiography devices during the forecasted period. For instance, in July 2021, Medtronic’s recalled 54,997 guidewire components used during angiography to place catheters into the vascular system because the devices were not sterilized before being shipped to hospitals. Also, in September 2021, Cordis Recalled its SUPER TORQUE MB angiographic catheter with radiopaque marker bands due to the potential for marker bands to move or mislodge. The FDA has recognized this as a Class I recall, the most serious recall.
COVID-19 Impact Analysis
The COVID-19 pandemic had a negative impact on the global Angiography Devices market since, during the pandemic, there was a large downfall in Angiography procedures. For instance, the British Cardiovascular Interventional society performed a retrospective analysis of all percutaneous coronary interventions (PCI) performed in the United Kingdom during the lockdown imposed by the pandemic in comparison with PCI volumes in the pre-pandemic period. The retrospective analysis concluded that there was 49% less PCI, with stable angina being hit the hardest, showing a 66% reduction, while the PCI for ST-elevation MI (STEMI) was down by 33%. Furthermore, the pandemic changed people's perspective toward healthy lifestyle choices, which caused a reduction in the cases of cardiovascular diseases, therefore impacting global angiography devices negatively.
Segment Analysis
Coronary heart disease is predicted to have a high demand during the forecast period (2022-2029).
Coronary heart disease is a heart disease in which the heart's arteries are unable to deliver sufficiently oxygen-rich blood to the heart muscles. It is the top reason for death. The reason for coronary heart disease relies on the type. Coronary artery disease is usually induced by cholesterol, a waxy substance that assembles up inside the lining of the coronary arteries, creating plaque. This buildup can partly or completely block blood flow in the heart's large arteries. The coronary microvascular condition occurs when the heart's tiny blood vessels do not typically work. For most individuals, coronary heart disease is preventable with a heart-healthy lifestyle.
Since the number of coronary heart disease cases is growing, coronary angiography is estimated to dominate the global angiography devices market throughout the forecast period. For instance, the American Heart Association estimated that globally, 244.1 million people were living with ischemic heart disease (IHD) in 2020, and it was more dominant in males than in females (141.0 and 103.1 million people, respectively). The highest prevalence rates of IHD were in North Africa and the Middle East, Central and South Asia, and Eastern Europe, and IHD mortality rates were highest in North Africa, the Middle East, Eastern Europe, and Central Asia in 2020. Thus, the mentioned data indicates that coronary angiography will dominate the global angiography devices market during the forecast period.
Geographical Analysis
North America is predicted to command the global angiography devices market.
North America is estimated to hold a large market over the forecast period (2022-2029) because of the growing cases of cardiovascular conditions and the existence of key market players in this region. For instance, according to the CDC, a U.S. American dies every 34 seconds because of cardiovascular disease. Cardiovascular disease caused over 697,000 deaths in 2020. Moreover, the existence of key market players such as Abbott, Haemonetics Corporation, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, and Cook Medical Inc., having considerable percentages of the global angiography devices market through different market strategies, are based in the United States, secures the dominance of this region over the global angiography devices market. For instance, in May 2022, Teleflex Incorporated, a leading global medical technology provider, was granted Health Canada approval for its MANTA Vascular Closure Device, the first commercially available biomechanical vascular closure device developed particularly for large bore femoral arterial access site closure. This approval marks an essential landmark in the regulatory strategy to extend the availability of the MANTA Device globally and delivers access to another uniquely developed device from Teleflex to Canadian clinicians.
Also, in January 2021, Haemonetics Corporation ("Haemonetics"), a global medical technology company concentrated on delivering inventive medical solutions to drive better patient outcomes, acquired a privately-held Cardiva Medical, Inc. ("Cardiva"), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Haemonetics enhances its penetration into the large and growing interventional cardiology and electrophysiology markets with this acquisition. Therefore, the data indicate that North America Holds most of the global market.
Competitive Landscape
The major global angiography devices market players are Abbott, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, B.Barun Melsungen, Siemens Healthineers, Lepu Medical, GE Healthcare, Haemonetics Corporation, and Cook Medical Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the Angiography Devices market globally. For instance, in October 2022, Lepu Medical obtained the MDR certificate issued by the BSI Netherlands Notified Body (2797) for its Ultraskin Hydrophilic Guide Wire and approved it for sale in the EU market. The certificate is valid for five years. Ultraskin Hydrophilic Guide Wire is the second product of Lepu Medical's high-risk class III product certified under MDR.
Medtronic, Plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
The product portfolio of Medtronic, Plc. for angiography devices contains Launcher: A coronary guide catheter comes with the performance advantages expected from a market leader, including a wide variety of curve shapes for transradial and femoral percutaneous coronary intervention (PCI).
The global angiography devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Growing Prevalence of Cardio-vascular diseases
4.1.1.2. Growing Geriatric Population
4.1.1.3. Market Strategies
4.1.2. Restraints
4.1.2.1. Product Market Recalls
4.1.2.2. Stringent Regulation
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Angiography Systems
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Catheters
7.4. Guidewires
7.5. Balloons
7.6. Contrast Media
7.7. Vascular Closure Devices
7.8. Angiography Accessories
8. By Application Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
8.1.2. Market Attractiveness Index, By Application Type
8.2. Diagnostic
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Therapeutic
9. By Technology Type
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
9.1.2. Market Attractiveness Index, By Technology Type
9.2. X-Ray
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. MRI
9.4. CT
10. By Procedure
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
10.1.2. Market Attractiveness Index, By Procedure
10.2. Coronary
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Endovascular
10.4. Neurovascular
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
13. Company Profiles
13.1. Medtronic Plc
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Abbott
13.3. Boston Scientific Corporation
13.4. Teleflex Incorporated
13.5. B.Barun Melsungen
13.6. Siemens Healthineers
13.7. Lepu Medical
13.8. GE Healthcare
13.9. Haemonetics Corporation
13.10. Cook Medical Inc.
LIST NOT EXHAUSTIVE
14. DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

언급된 주요 기업들

Medtronic Plc, Abbott, Boston Scientific Corporation, Teleflex Incorporated, B.Barun Melsungen, Siemens Healthineers, Lepu Medical, GE Healthcare, Haemonetics Corporation, Cook Medical Inc.

표 목록 (Tables)

List of Tables Table 1 Global Angiography Devices Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Angiography Devices Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Angiography Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Angiography Devices Market Value, By End‑User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Angiography Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Angiography Devices Market Value, By Product, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Angiography Devices Market Value, By Product, 2022-2033 (US$ Billion)

Table 8 Global Angiography Devices Market Value, By Technology, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Angiography Devices Market Value, By Technology, 2022-2033 (US$ Billion)

Table 10 Global Angiography Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Angiography Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 12 Global Angiography Devices Market Value, By End‑User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Angiography Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 14 Global Angiography Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Angiography Devices Market Value, By Region, 2022-2033 (US$ Billion)

Table 16 North America Angiography Devices Market Value, By Product, 2022-2033 (US$ Billion)

Table 17 North America Angiography Devices Market Value, By Technology, 2022-2033 (US$ Billion)

Table 18 North America Angiography Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 19 North America Angiography Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 20 North America Angiography Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Europe Angiography Devices Market Value, By Product, 2022-2033 (US$ Billion)

Table 22 Europe Angiography Devices Market Value, By Technology, 2022-2033 (US$ Billion)

Table 23 Europe Angiography Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 24 Europe Angiography Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 25 Europe Angiography Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 26 Asia-Pacific Angiography Devices Market Value, By Product, 2022-2033 (US$ Billion)

Table 27 Asia-Pacific Angiography Devices Market Value, By Technology, 2022-2033 (US$ Billion)

Table 28 Asia-Pacific Angiography Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 29 Asia-Pacific Angiography Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 30 Asia-Pacific Angiography Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 31 South America Angiography Devices Market Value, By Product, 2022-2033 (US$ Billion)

Table 32 South America Angiography Devices Market Value, By Technology, 2022-2033 (US$ Billion)

Table 33 South America Angiography Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 34 South America Angiography Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 35 South America Angiography Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 36 Middle East and Africa Angiography Devices Market Value, By Product, 2022-2033 (US$ Billion)

Table 37 Middle East and Africa Angiography Devices Market Value, By Technology, 2022-2033 (US$ Billion)

Table 38 Middle East and Africa Angiography Devices Market Value, By Application, 2022-2033 (US$ Billion)

Table 39 Middle East and Africa Angiography Devices Market Value, By End‑User, 2022-2033 (US$ Billion)

Table 40 Middle East and Africa Angiography Devices Market Value, By Country, 2022-2033 (US$ Billion)

Table 41 Siemens Healthcare Private Limited: Overview

Table 42 Siemens Healthcare Private Limited: Product Portfolio

Table 43 Siemens Healthcare Private Limited: Key Developments

Table 44 Medtronic: Overview

Table 45 Medtronic: Product Portfolio

Table 46 Medtronic: Key Developments

Table 47 Abbott: Overview

Table 48 Abbott: Product Portfolio

Table 49 Abbott: Key Developments

Table 50 Boston Scientific Corporation: Overview

Table 51 Boston Scientific Corporation: Product Portfolio

Table 52 Boston Scientific Corporation: Key Developments

Table 53 AngioDynamics: Overview

Table 54 AngioDynamics: Product Portfolio

Table 55 AngioDynamics: Key Developments

Table 56 Terumo Medical Corporation: Overview

Table 57 Terumo Medical Corporation: Product Portfolio

Table 58 Terumo Medical Corporation: Key Developments

Table 59 GE HealthCare: Overview

Table 60 GE HealthCare: Product Portfolio

Table 61 GE HealthCare: Key Developments

Table 62 CANON MEDICAL SYSTEMS CORPORATION: Overview

Table 63 CANON MEDICAL SYSTEMS CORPORATION: Product Portfolio

Table 64 CANON MEDICAL SYSTEMS CORPORATION: Key Developments

Table 65 Merit Medical Systems: Overview

Table 66 Merit Medical Systems: Product Portfolio

Table 67 Merit Medical Systems: Key Developments

Table 68 Cook: Overview

Table 69 Cook: Product Portfolio

Table 70 Cook: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Angiography Devices Market Share, By Product, 2024 & 2033 (%)

Figure 3 Global Angiography Devices Market Share, By Technology, 2024 & 2033 (%)

Figure 4 Global Angiography Devices Market Share, By Application, 2024 & 2033 (%)

Figure 5 Global Angiography Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 6 Global Angiography Devices Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Angiography Devices Market Y-o-Y Growth, By Product, 2023-2033 (%)

Figure 8 Angiography Systems Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 9 Catheters Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 10 Guidewires Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 11: Balloon Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 12 Others Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 13 Global Angiography Devices Market Y-o-Y Growth, By Technology, 2023-2033 (%)

Figure 14 X-Ray Technology in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 15 Magnetic Resonance Technology in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 16 Computed Tomography Technology in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 17: Other Technologies in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 18 Global Angiography Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 19 Coronary Application in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 20 Endovascular Application in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 21 Neurovascular Application in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 22 Onco Application in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 23 Others Application in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 24 Global Angiography Devices Market Y-o-Y Growth, By End‑User, 2023-2033 (%)

Figure 25 Hospitals and Clinics End‑User in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 26 Diagnostic and Imaging Centers End‑User in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 27: Other End‑Users in Global Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 28 Global Angiography Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 29 North America Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 30 North America Angiography Devices Market Share, By Product, 2024 & 2033 (%)

Figure 31 North America Angiography Devices Market Share, By Technology, 2024 & 2033 (%)

Figure 32 North America Angiography Devices Market Share, By Application, 2024 & 2033 (%)

Figure 33 North America Angiography Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 34 North America Angiography Devices Market Share, By Country, 2024 & 2033 (%)

Figure 35 Europe Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 36 Europe Angiography Devices Market Share, By Product, 2024 & 2033 (%)

Figure 37 Europe Angiography Devices Market Share, By Technology, 2024 & 2033 (%)

Figure 38 Europe Angiography Devices Market Share, By Application, 2024 & 2033 (%)

Figure 39 Europe Angiography Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 40 Europe Angiography Devices Market Share, By Country, 2024 & 2033 (%)

Figure 41 Asia-Pacific Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 42 Asia-Pacific Angiography Devices Market Share, By Product, 2024 & 2033 (%)

Figure 43 Asia-Pacific Angiography Devices Market Share, By Technology, 2024 & 2033 (%)

Figure 44 Asia-Pacific Angiography Devices Market Share, By Application, 2024 & 2033 (%)

Figure 45 Asia-Pacific Angiography Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 46 Asia-Pacific Angiography Devices Market Share, By Country, 2024 & 2033 (%)

Figure 47 South America Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 48 South America Angiography Devices Market Share, By Product, 2024 & 2033 (%)

Figure 49 South America Angiography Devices Market Share, By Technology, 2024 & 2033 (%)

Figure 50 South America Angiography Devices Market Share, By Application, 2024 & 2033 (%)

Figure 51 South America Angiography Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 52 South America Angiography Devices Market Share, By Country, 2024 & 2033 (%)

Figure 53 Middle East and Africa Angiography Devices Market Value, 2022-2033 (US$ Billion)

Figure 54 Middle East and Africa Angiography Devices Market Share, By Product, 2024 & 2033 (%)

Figure 55 Middle East and Africa Angiography Devices Market Share, By Technology, 2024 & 2033 (%)

Figure 56 Middle East and Africa Angiography Devices Market Share, By Application, 2024 & 2033 (%)

Figure 57 Middle East and Africa Angiography Devices Market Share, By End‑User, 2024 & 2033 (%)

Figure 58 Siemens Healthcare Private Limited: Financials

Figure 59 Medtronic: Financials

Figure 60 Abbott: Financials

Figure 61 Boston Scientific Corporation: Financials

Figure 62 AngioDynamics: Financials

Figure 63 Terumo Medical Corporation: Financials

Figure 64 GE HealthCare: Financials

Figure 65 CANON MEDICAL SYSTEMS CORPORATION: Financials

Figure 66 Merit Medical Systems: Financials

Figure 67 Cook: Financials

글로벌 혈관조영기기 시장 – 2023-2030

Global Angiography Devices Market - 2023-2030